Schonfeld Strategic Advisors’s Translational Development Acquisition Corp Units TDACU Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACU
AIMCA
RCM
MI
YCM
FTUS
Schonfeld Strategic Advisors's TDACU Position: Q2 2025 in Review
Schonfeld Strategic Advisors sold out of Translational Development Acquisition Corp Units (TDACU) in Q2 2025, closing a stake of 25,100 shares — an estimated $255K sold.
Schonfeld Strategic Advisors first reported a position in TDACU in Q1 2025 and held it in 1 quarter. The position peaked at $255K in Q1 2025. 9 funds tracked by Wall St. Rank hold TDACU as of Q2 2025.
- Schonfeld Strategic Advisors reported no remaining Translational Development Acquisition Corp Units position as of Q2 2025 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 25,100 Translational Development Acquisition Corp Units shares in Q2 2025, an estimated $255K.
- Schonfeld Strategic Advisors first reported a position in Translational Development Acquisition Corp Units in Q1 2025 and held it in 1 quarter.
- Schonfeld Strategic Advisors's Translational Development Acquisition Corp Units position peaked at $255K in Q1 2025.
- 9 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q2 2025.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.